Philips (China)
Philips introduces integrated innovative solutions with advanced technology, rich clinical experience and deep consumer insights. The company is currently a leader in diagnostic imaging, image-guided therapy, patient monitoring, health informatics, and consumer health and home care. Headquartered in the Netherlands, Philips' health technology business had sales of 17.8 billion euros in 2017, with approximately 74,000 employees worldwide, and sales and services in more than 100 countries around the world.
2 past transactions
PVmed
Series A in 2022
PVmed is a medical technology company founded in 2017 and headquartered in Guangzhou, China. The company specializes in the development of artificial intelligence products aimed at enhancing auxiliary diagnosis and treatment in the healthcare sector. PVmed has created advanced medical imaging analysis technology that is particularly effective for conditions such as nasopharyngeal cancer, lung cancer, and breast cancer. By leveraging AI, PVmed enables healthcare professionals and patients to utilize high-quality diagnostic tools, facilitating efficient disease management and treatment.
Pulse
Series C in 2021
Pulse is a health care service provider that assess coronary physiology and biomechanics through innovative techniques.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.